PCO371

Aha kemịkalụ:

1- (3,5-dimethyl-4- (2- ((4-oxo-2---- (4--trifluoromethoxy) phenyl) -1,3,8-triazaspiro [4.5] dec-1-en-8-yl Sufonyl) ethyl) phenyl) -5,5-dimethylimidazolidine-2,4-dione.

Koodu Ọchịchọ:

O=C1NC(C(C)(C)N1C2=CC(C)=C(CCS(=O)(N(CC3)CCC3(N=C(C4=CC=C)(OC(F)(F)F) )C=C4)N5)C5=O)=O)C(C)=C2)=O

Koodu InChi:

InChi=1S/C29H32F3N5O6S/c1-17-15-20(37-26(40)34-24(38)27(37,3)4)16-18(2)22(17)9-14-44 41,42)36-12-10-28 (11 -13-36)25(39)33-23(35-28)19-5-7-21(8-6-19)43-29(30,31)32/h5-8,15-16H,9 -14H2,1-4H3,(H,33,35,39)(H,34,38,40)

Igodo InChi:

LDZJFVOUPUFOHX-UHFFFAOYSA-N

Okwu:

PCO371; PCO-371; PCO 371

Solubility: 

Nchekwa: 

Nkọwa:

PCO371 bụ agonist PTHR1 dị ike ma họrọ maka ọgwụgwọ hypoparathyroidism. Nlekọta ọnụ nke PCO371 na oke osteopenic na-akpalite mmụba dị ukwuu na ntụgharị ọkpụkpụ na mmụba dị nta nke ọkpụkpụ ọkpụkpụ. Na oke hypocalcemic, PCO371 na-eweghachi ọkwa calcium serum na-enweghị ịba ụba calcium nke urinary, yana mmetụta siri ike na ogologo oge karịa injections PTH.

Ebumnuche: PTHR1